116 related articles for article (PubMed ID: 29891024)
21. Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1.
Watanabe Y; Nakajima M; Ohashi N; Kume T; Yokoi T
Drug Metab Dispos; 2003 May; 31(5):589-95. PubMed ID: 12695347
[TBL] [Abstract][Full Text] [Related]
22. Effects of ketoconazole on glucuronidation by UDP-glucuronosyltransferase enzymes.
Yong WP; Ramirez J; Innocenti F; Ratain MJ
Clin Cancer Res; 2005 Sep; 11(18):6699-704. PubMed ID: 16166450
[TBL] [Abstract][Full Text] [Related]
23. Structure-inhibition relationship of podophyllotoxin (PT) analogues towards UDP-glucuronosyltransferase (UGT) isoforms.
Qi JQ; Cao YF; Sun XY; Hong M; Fang ZZ; Meng DL; Sun DX
Pharmazie; 2015 Apr; 70(4):239-43. PubMed ID: 26012253
[TBL] [Abstract][Full Text] [Related]
24. Identification of UDP-glucuronosyltransferase isoforms responsible for leonurine glucuronidation in human liver and intestinal microsomes.
Tan B; Cai W; Zhang J; Zhou N; Ma G; Yang P; Zhu Q; Zhu Y
Xenobiotica; 2014 Sep; 44(9):775-84. PubMed ID: 24635759
[TBL] [Abstract][Full Text] [Related]
25. Acyl glucuronidation of fluoroquinolone antibiotics by the UDP-glucuronosyltransferase 1A subfamily in human liver microsomes.
Tachibana M; Tanaka M; Masubuchi Y; Horie T
Drug Metab Dispos; 2005 Jun; 33(6):803-11. PubMed ID: 15769885
[TBL] [Abstract][Full Text] [Related]
26. In vitro glucuronidation of the primary metabolite of 10-chloromethyl-11-demethyl-12-oxo-calanolide A by human liver microsomes and its interactions with UDP-glucuronosyltransferase substrates.
Liu X; Sheng L; Zhao M; Mi J; Liu Z; Li Y
Drug Metab Pharmacokinet; 2015 Feb; 30(1):89-96. PubMed ID: 25760535
[TBL] [Abstract][Full Text] [Related]
27. Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases.
Hoehle SI; Pfeiffer E; Metzler M
Mol Nutr Food Res; 2007 Aug; 51(8):932-8. PubMed ID: 17628876
[TBL] [Abstract][Full Text] [Related]
28. The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver.
Girard H; Villeneuve L; Court MH; Fortier LC; Caron P; Hao Q; von Moltke LL; Greenblatt DJ; Guillemette C
Drug Metab Dispos; 2006 Jul; 34(7):1220-8. PubMed ID: 16595709
[TBL] [Abstract][Full Text] [Related]
29. Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms.
Zhu L; Ge G; Zhang H; Liu H; He G; Liang S; Zhang Y; Fang Z; Dong P; Finel M; Yang L
Drug Metab Dispos; 2012 Mar; 40(3):529-38. PubMed ID: 22180045
[TBL] [Abstract][Full Text] [Related]
30. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation.
Miners JO; Bowalgaha K; Elliot DJ; Baranczewski P; Knights KM
Drug Metab Dispos; 2011 Apr; 39(4):644-52. PubMed ID: 21245288
[TBL] [Abstract][Full Text] [Related]
31. High-performance liquid chromatographic assay for glucuronidation activity of 7-ethyl-10-hydroxycamptothecin (SN-38), the active metabolite of irinotecan (CPT-11), in human liver microsomes.
Hanioka N; Jinno H; Nishimura T; Ando M; Ozawa S; Sawada J
Biomed Chromatogr; 2001 Aug; 15(5):328-33. PubMed ID: 11507714
[TBL] [Abstract][Full Text] [Related]
32. Differential rates of glucuronidation for 7-ethyl-10-hydroxy-camptothecin (SN-38) lactone and carboxylate in human and rat microsomes and recombinant UDP-glucuronosyltransferase isoforms.
Tallman MN; Ritter JK; Smith PC
Drug Metab Dispos; 2005 Jul; 33(7):977-83. PubMed ID: 15833930
[TBL] [Abstract][Full Text] [Related]
33. The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferases.
Ethell BT; Anderson GD; Burchell B
Biochem Pharmacol; 2003 May; 65(9):1441-9. PubMed ID: 12732356
[TBL] [Abstract][Full Text] [Related]
34. Identification of human UDP-glucuronosyltransferases involved in N-carbamoyl glucuronidation of lorcaserin.
Sadeque AJ; Usmani KA; Palamar S; Cerny MA; Chen WG
Drug Metab Dispos; 2012 Apr; 40(4):772-8. PubMed ID: 22259019
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of beta-glucuronidase by natural glucuronides of kampo medicines using glucuronide of SN-38 (7-ethyl-10-hydroxycamptothecin) as a substrate.
Narita M; Nagai E; Hagiwara H; Aburada M; Yokoi T; Kamataki T
Xenobiotica; 1993 Jan; 23(1):5-10. PubMed ID: 8484262
[TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of bergenin.
Song H; Wang J; Zhang R; Liu X; Yuan G; Wei C; Wang B; Guo R
Biomed Chromatogr; 2014 Mar; 28(3):348-53. PubMed ID: 23996546
[TBL] [Abstract][Full Text] [Related]
37. Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver.
Mano Y; Usui T; Kamimura H
Pharm Res; 2006 Jul; 23(7):1502-8. PubMed ID: 16783480
[TBL] [Abstract][Full Text] [Related]
38. Hepatic UDP-glucuronosyltransferase is responsible for eslicarbazepine glucuronidation.
Loureiro AI; Fernandes-Lopes C; Bonifácio MJ; Wright LC; Soares-da-Silva P
Drug Metab Dispos; 2011 Sep; 39(9):1486-94. PubMed ID: 21673130
[TBL] [Abstract][Full Text] [Related]
39. Assessment of UDP-glucuronosyltransferase catalyzed formation of Picroside II glucuronide in microsomes of different species and recombinant UGTs.
Li T; Zheng Y; Fu F; Ji H; Chen X; Zhao Y; Zhao D; Li N; Zhang L
Xenobiotica; 2011 Jul; 41(7):530-7. PubMed ID: 21524190
[TBL] [Abstract][Full Text] [Related]
40. Hepatic UDP-glucuronosyltransferases responsible for glucuronidation of thyroxine in humans.
Kato Y; Ikushiro S; Emi Y; Tamaki S; Suzuki H; Sakaki T; Yamada S; Degawa M
Drug Metab Dispos; 2008 Jan; 36(1):51-5. PubMed ID: 17908920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
